Related Experiment Video
Updated: Aug 5, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
[Clonidine treatment in manic episodes]
1Spitalul Gh. Marinescu, Bucureşti.
Abstract:
The authors have treated 20 patients hospitalized for acute manic disorders with 450-750 micrograms of clonidine per day for a period of one month. The tolerance to the drug was excellent. A marked decrease in manic symptoms was noted in 65% of the patients after the first ten days of therapy. The response was rapid and was maintained for the entire duration of the study, and clonidine was efficient for all the symptoms of the manic syndrome. The supra-sedation effect was much lower than with neuroleptics, and clonidine could be considered to represent a practical progress in the acute therapy of manic patients. Clonidine, usually employed as an anti-hypertensive drug, is an alpha-2-adrenergic agonist. It is believed that this property decreases the neural transmission by noradrenaline by stimulating pre-synapsis inhibitor receptors.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drug Therapy
Antianxiety Medications

